BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  US Device


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


Purdue Pharma L.P. (Connecticut) 

One Stamford Forum
Stamford  Connecticut  06901-3431  U.S.A.
Phone: 203-588-8000 Fax: 203-588-8850


View Clinical Trials from BioPharm Insight

Purdue Pharma L.P., headquartered in Stamford, CT, is a privately held pharmaceutical company founded by physicians and focused on meeting the needs of healthcare providers and the patients in their care. Together with its independent associated companies, Purdue is dedicated to finding, developing, and bringing to market new medicines and related products that improve health outcomes. The company has long been known for its pioneering research on persistent pain, a principal cause of human suffering.

Purdue also has a growing line of non-prescription products including laxatives, microbicides, and nutraceuticals. The company is dedicated to serving the evolving needs of healthcare providers, patients, and caregivers with prescription and non-prescription medicines. A commitment to innovation and caring spans every aspect of the organization, from discovering and launching new medicines to demonstrating their medical value.

Purdue has led the battle against inadequate treatment of pain by developing sustained-release medications to manage pain. Its sales, marketing, and medical education professionals provide the healthcare community with comprehensive educational materials and programs relating to pain management.

In 1993, Purdue established Partners Against Pain® as a resource to help patients, caregivers, and healthcare professionals advance standards of pain care and alleviate unnecessary suffering through education and advocacy. Purdue has also assumed a leading role in addressing the serious public health problem of prescription drug abuse, supporting programs intended to help stem abuse.

At its research facilities in Cranbury, New Jersey, Purdue scientists are discovering new compounds to treat pain and developing formulations and delivery systems to help improve patient safety.

 Key Statistics

Ownership: Private

Web Site: Purdue Pharma L.P.
Employees: 1,650


 Company News
Zogenix, Inc. (ZGNX) Falls As Rival Purdue Pharma L.P. Announces Positive Phase 3 Trial Of Abuse-Resistant Pill 3/12/2014 7:14:26 AM    More...
Jobs Cut As Purdue Pharma L.P. Restructures 2/17/2014 7:43:36 AM    More...
Purdue Pharma L.P. Names Mark Timney President And Chief Executive Officer 1/27/2014 6:44:41 AM    More...
Purdue Pharma L.P. Announces Resolution Of OxyContin® (Oxycodone HCl Controlled-Release) Tablets CII Patent Lawsuit With IMPAX Laboratories, Inc. (IPXL) 12/3/2013 11:46:13 AM    More...
FDA Accepts For Review Purdue Pharma L.P.'s New Drug Application For Targiniq™ ER (oxycodone HCl/naloxone HCL Controlled-Release) Tablets CII 11/26/2013 8:49:24 AM    More...
Purdue Pharma L.P. Receives FDA Approval for 15 mcg/hour Dosage Strength of Butrans® (Buprenorphine) Transdermal System CIII 9/24/2013 10:50:21 AM    More...
Purdue Pharma L.P. to Present Data pn Long-Term Analgesic Efficacy of Opioid Therapy 9/6/2013 9:12:35 AM    More...
Purdue Pharma L.P. Presents United Kingdom Data on Opioid Dosage Strength as a Predictor of Overdose Risk at International Society For Pharmacoepidemiology Conference 8/29/2013 8:46:29 AM    More...
Purdue Pharma L.P. to Present Data Examining the Inverse Association Between Overdose Risk and Age at International Conference on Opioids 6/7/2013 12:38:54 PM    More...
Grünenthal Group and Purdue Pharma L.P. Enter Into a Licensing Agreement 5/28/2013 9:45:18 AM    More...